Registration
ARENTFOX SCHIFF LLP for TRANSPARENCY RISING CORP.
Firm
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmacy Benefit Manager reform; Transparency in prescription drug markets; Prescription drug prices; H.R. 7148 (Consolidated Appropriations Act, 2026), regarding Pharmacy Benefit Manager reform, transparency in prescription drug markets, and prescription drug prices; H.R. 6609 and H.R. 6610 (Pharmacists Fight Back Act), generally; H.R. 5582 and S. 2355 (Patients Deserve Price Tags Act), generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILIP ENGLISH New | U.S. Representative (1995-2009) |
| KATHERINE KRAMER New | Intern/Fellow, Rep. Emanuel Cleaver (2017-2019) |
| DANIEL SJOSTEDT New | Staff Assistant, Rep. Jeff Fortenberry (2016-2017) |
| BLAKE THELANDER New | Health Policy Advisor/Legislative Director, Rep. Mariannette Miller-Meeks (2023-2025), Staff Assistant/Legislative Assistant/Senior Legislative Assistant, Rep. Jefferson Van Drew (2020-2023), Intern, Rep. Ralph Norman (2019-2019) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.